Saini SS - Search Results

1

Pros and cons of treating murine myasthenia gravis with anti-C1q antibody.

Tüzün E, Li J, Saini SS, Yang H, Christadoss P. Tüzün E, et al. Among authors: saini ss. J Neuroimmunol. 2007 Jan;182(1-2):167-76. doi: 10.1016/j.jneuroim.2006.10.014. Epub 2006 Nov 29. J Neuroimmunol. 2007. PMID: 17137637

2

The cDNA of mouse skeletal muscle transcribe for both isoforms 1 and 2 of acetylcholine receptor alpha subunit.

Saini SS, Tüzün E, Christadoss P. Saini SS, et al. J Neuroimmunol. 2005 Dec;169(1-2):177-9. doi: 10.1016/j.jneuroim.2005.08.013. Epub 2005 Sep 26. J Neuroimmunol. 2005. PMID: 16185772

3

Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.

Tüzün E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P. Tüzün E, et al. Among authors: saini ss. Neuromuscul Disord. 2006 Feb;16(2):137-43. doi: 10.1016/j.nmd.2005.11.005. Epub 2006 Jan 19. Neuromuscul Disord. 2006. PMID: 16427283

4

Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis.

Tüzün E, Saini SS, Yang H, Alagappan D, Higgs S, Christadoss P. Tüzün E, et al. Among authors: saini ss. J Neuroimmunol. 2006 May;174(1-2):157-67. doi: 10.1016/j.jneuroim.2006.01.015. Epub 2006 Mar 9. J Neuroimmunol. 2006. PMID: 16527362

5

Complement regulator CD59 deficiency fails to augment susceptibility to actively induced experimental autoimmune myasthenia gravis.

Tüzün E, Saini SS, Morgan BP, Christadoss P. Tüzün E, et al. Among authors: saini ss. J Neuroimmunol. 2006 Dec;181(1-2):29-33. doi: 10.1016/j.jneuroim.2006.07.016. Epub 2006 Oct 23. J Neuroimmunol. 2006. PMID: 17056125

6

A new mouse model of autoimmune ocular myasthenia gravis.

Yang H, Wu B, Tüzün E, Saini SS, Li J, Allman W, Higgs S, Xiao TL, Christadoss P. Yang H, et al. Among authors: saini ss. Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5101-11. doi: 10.1167/iovs.07-0271. Invest Ophthalmol Vis Sci. 2007. PMID: 17962462

7

Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis.

Li J, Tüzün E, Wu XR, Qi HB, Allman W, Saini SS, Christadoss P. Li J, et al. Among authors: saini ss. J Neuroimmunol. 2008 Feb;194(1-2):44-53. doi: 10.1016/j.jneuroim.2007.11.005. Epub 2008 Jan 18. J Neuroimmunol. 2008. PMID: 18207575

8

C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis.

Qi H, Tüzün E, Allman W, Saini SS, Penabad ZR, Pierangeli S, Christadoss P. Qi H, et al. Among authors: saini ss. J Neuroimmunol. 2008 May 30;196(1-2):101-6. doi: 10.1016/j.jneuroim.2008.03.007. Epub 2008 May 1. J Neuroimmunol. 2008. PMID: 18455242 Free PMC article.

9

Classical complement pathway in experimental autoimmune myasthenia gravis pathogenesis.

Christadoss P, Tüzün E, Li J, Saini SS, Yang H. Christadoss P, et al. Among authors: saini ss. Ann N Y Acad Sci. 2008;1132:210-9. doi: 10.1196/annals.1405.009. Ann N Y Acad Sci. 2008. PMID: 18567870

10

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis.

Li J, Qi H, Tüzün E, Allman W, Yilmaz V, Saini SS, Deymeer F, Saruhan-Direskeneli G, Christadoss P. Li J, et al. Among authors: saini ss. J Neuroimmunol. 2009 Mar 31;208(1-2):40-5. doi: 10.1016/j.jneuroim.2008.12.013. Epub 2009 Feb 3. J Neuroimmunol. 2009. PMID: 19193448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters